Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

E K Bergsland1, A P Venook

  • 1Division of Hematology and Oncology, University of California, San Francisco, USA.

Current Opinion in Oncology
|July 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance).

ESMO open·2025
Same author

A phase II study of axitinib in advanced neuroendocrine tumors.

Endocrine-related cancer·2016
Same author

Transcatheter pulmonic valve replacement in carcinoid heart disease.

European heart journal. Cardiovascular Imaging·2015
Same author

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.

British journal of cancer·2013
Same author

Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

Oncogene·2013
Same author

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Hepatocellular carcinoma (HCC) management is challenging due to rising incidence. Early detection and innovative therapies offer hope for this difficult-to-treat liver cancer.

Area of Science:

  • Hepatology and oncology, focusing on liver cancer research.

Background:

  • Hepatocellular carcinoma (HCC) incidence is rising globally, posing significant clinical challenges.
  • Effective management strategies for HCC are urgently needed due to its complexity.

Purpose of the Study:

  • To review current challenges and opportunities in Hepatocellular carcinoma (HCC) management.
  • To explore advancements in early detection, surgical techniques, and adjuvant therapies for HCC.

Main Methods:

  • Review of current literature on Hepatocellular carcinoma (HCC) diagnosis and treatment.
  • Analysis of emerging surgical and postoperative therapeutic options.
  • Evaluation of regional treatments and chemotherapy efficacy.

Main Results:

  • Early detection of Hepatocellular carcinoma (HCC) is feasible in at-risk populations.

Related Experiment Videos

  • Surgical interventions and adjuvant therapies show promise for resectable HCC.
  • Efficacy of regional treatments remains unproven; combination chemotherapy requires validation.

    • Conclusions:

    • Elucidating the genetic and molecular features of Hepatocellular carcinoma (HCC) is crucial.
    • Innovative strategies are needed to improve outcomes for unresectable HCC.
    • Further research into novel therapeutic approaches is essential for managing this liver cancer.